AbsoluteRiskFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.BrachytherapyGeneticCounselingDown-StagingHER-2AxillarySamplingMRIHormoneReplacementTherapyMastodyniaBRCAGeneAntiemeticImmunotherapyPI3KinaseInhibitorsmTORInhibitorsLymphoscintigraphyOligometastasesDocetaxelNeoadjuvantTherapyER+Self-examinationIn-situCarcinomaCytotoxicBilateralProphylacticMastectomyDimplingMegestrolAcetateMetastasisCAMAdenocarcinomaApoptosisAromataseInhibitorsGenomicTestingTyrosine-KinaseInhibitorAdvocacyAntibodyTherapyRelapseLumpIntraductalPapillomaPathologicResponseDoxorubicinCDK4/6InhibitorsMultimodalityTherapyMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltCachexiaPrecisionMedicineGermlineMutationBreastCancerCMFChemotherapyCystWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.Estimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearBreastTomosynthesisStagingSERMECOGScorePARPInhibitorsCyclophosphamideKi-67RatePhyllodesTumorTamoxifenAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerDoseDenseTherapyHerceptinRadiotherapyBI-RADSTriple +/-BreastCancerBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55CalcificationsWomen ages40+ shouldhave a clinicalbreast examat least yearlyGuaranteedRenewableInsuranceChemotherapyFISHEstrogenACChemotherapyFlowCytometryGailModelCo-survivorEGFRChemopreventionBOCAMethotrexateLCISER-1 in 8womenMastectomyDefinitiveSurgeryTumorGradeLapatinibMultifocalTumorsPhysicalactivity mayreduce therisk of breastcancersCapecitabinePagetDisease5-FluorouracilGeneticPredispositionAngiogenesisPalbociclibAyurvedaPalpationAlopeciaOvarianSuppressionCheckpointInhibitorRADRaloxifeneMorpheaLumpectomyFamilyHistoryEstradiolAdjuvantTherapyLymphNodeStatusHormoneReceptorStatusBiopsyKappaEpsilonAnastrozoleAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenFibroadenomaBevacizumabProgestinPaclitaxelCytostaticGeneMutationAbsoluteRiskFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.BrachytherapyGeneticCounselingDown-StagingHER-2AxillarySamplingMRIHormoneReplacementTherapyMastodyniaBRCAGeneAntiemeticImmunotherapyPI3KinaseInhibitorsmTORInhibitorsLymphoscintigraphyOligometastasesDocetaxelNeoadjuvantTherapyER+Self-examinationIn-situCarcinomaCytotoxicBilateralProphylacticMastectomyDimplingMegestrolAcetateMetastasisCAMAdenocarcinomaApoptosisAromataseInhibitorsGenomicTestingTyrosine-KinaseInhibitorAdvocacyAntibodyTherapyRelapseLumpIntraductalPapillomaPathologicResponseDoxorubicinCDK4/6InhibitorsMultimodalityTherapyMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltCachexiaPrecisionMedicineGermlineMutationBreastCancerCMFChemotherapyCystWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.Estimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearBreastTomosynthesisStagingSERMECOGScorePARPInhibitorsCyclophosphamideKi-67RatePhyllodesTumorTamoxifenAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerDoseDenseTherapyHerceptinRadiotherapyBI-RADSTriple +/-BreastCancerBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55CalcificationsWomen ages40+ shouldhave a clinicalbreast examat least yearlyGuaranteedRenewableInsuranceChemotherapyFISHEstrogenACChemotherapyFlowCytometryGailModelCo-survivorEGFRChemopreventionBOCAMethotrexateLCISER-1 in 8womenMastectomyDefinitiveSurgeryTumorGradeLapatinibMultifocalTumorsPhysicalactivity mayreduce therisk of breastcancersCapecitabinePagetDisease5-FluorouracilGeneticPredispositionAngiogenesisPalbociclibAyurvedaPalpationAlopeciaOvarianSuppressionCheckpointInhibitorRADRaloxifeneMorpheaLumpectomyFamilyHistoryEstradiolAdjuvantTherapyLymphNodeStatusHormoneReceptorStatusBiopsyKappaEpsilonAnastrozoleAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenFibroadenomaBevacizumabProgestinPaclitaxelCytostaticGeneMutation

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
  1. Absolute Risk
  2. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  3. Brachytherapy
  4. Genetic Counseling
  5. Down-Staging
  6. HER-2
  7. Axillary Sampling
  8. MRI
  9. Hormone Replacement Therapy
  10. Mastodynia
  11. BRCA Gene
  12. Antiemetic
  13. Immunotherapy
  14. PI3 Kinase Inhibitors
  15. mTOR Inhibitors
  16. Lymphoscintigraphy
  17. Oligometastases
  18. Docetaxel
  19. Neoadjuvant Therapy
  20. ER+
  21. Self-examination
  22. In-situ Carcinoma
  23. Cytotoxic
  24. Bilateral Prophylactic Mastectomy
  25. Dimpling
  26. Megestrol Acetate
  27. Metastasis
  28. CAM
  29. Adenocarcinoma
  30. Apoptosis
  31. Aromatase Inhibitors
  32. Genomic Testing
  33. Tyrosine-Kinase Inhibitor
  34. Advocacy
  35. Antibody Therapy
  36. Relapse
  37. Lump
  38. Intraductal Papilloma
  39. Pathologic Response
  40. Doxorubicin
  41. CDK4/6 Inhibitors
  42. Multimodality Therapy
  43. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  44. Cachexia
  45. Precision Medicine
  46. Germline Mutation
  47. Breast Cancer
  48. CMF Chemotherapy
  49. Cyst
  50. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  51. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  52. Breast Tomosynthesis
  53. Staging
  54. SERM
  55. ECOG Score
  56. PARP Inhibitors
  57. Cyclophosphamide
  58. Ki-67 Rate
  59. Phyllodes Tumor
  60. Tamoxifen
  61. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  62. Dose Dense Therapy
  63. Herceptin
  64. Radiotherapy
  65. BI-RADS
  66. Triple +/- Breast Cancer
  67. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  68. Calcifications
  69. Women ages 40+ should have a clinical breast exam at least yearly
  70. Guaranteed Renewable Insurance
  71. Chemotherapy
  72. FISH
  73. Estrogen
  74. AC Chemotherapy
  75. Flow Cytometry
  76. Gail Model
  77. Co-survivor
  78. EGFR
  79. Chemoprevention
  80. BOCA
  81. Methotrexate
  82. LCIS
  83. ER-
  84. 1 in 8 women
  85. Mastectomy
  86. Definitive Surgery
  87. Tumor Grade
  88. Lapatinib
  89. Multifocal Tumors
  90. Physical activity may reduce the risk of breast cancers
  91. Capecitabine
  92. Paget Disease
  93. 5-Fluorouracil
  94. Genetic Predisposition
  95. Angiogenesis
  96. Palbociclib
  97. Ayurveda
  98. Palpation
  99. Alopecia
  100. Ovarian Suppression
  101. Checkpoint Inhibitor
  102. RAD
  103. Raloxifene
  104. Morphea
  105. Lumpectomy
  106. Family History
  107. Estradiol
  108. Adjuvant Therapy
  109. Lymph Node Status
  110. Hormone Receptor Status
  111. Biopsy
  112. Kappa Epsilon
  113. Anastrozole
  114. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  115. Fibroadenoma
  116. Bevacizumab
  117. Progestin
  118. Paclitaxel
  119. Cytostatic
  120. Gene Mutation